期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
海参低聚肽和大豆糖肽及其混合物的抗缺氧作用
1
作者 许博林 辛元尧 +5 位作者 周雪姣 年永琼 杨梦 乔一杰 杨建鑫 李向阳 《中国高原医学与生物学杂志》 CAS 2018年第2期95-101,共7页
目的探讨海参低聚肽和大豆糖肽及两者混合物的抗缺氧作用。方法检测常压密闭实验及低压密闭实验(低压氧舱模拟6000米海拔)小鼠LD、LDH、SOD、MDA及存活时间、血常规等指标进行相关分析。结果与空白对照组比较,多次给予海参低聚肽和大豆... 目的探讨海参低聚肽和大豆糖肽及两者混合物的抗缺氧作用。方法检测常压密闭实验及低压密闭实验(低压氧舱模拟6000米海拔)小鼠LD、LDH、SOD、MDA及存活时间、血常规等指标进行相关分析。结果与空白对照组比较,多次给予海参低聚肽和大豆糖肽,中剂量分别显著延长小鼠常压密闭缺氧存活时间17.22%、23.89%;高剂量延长17.47%、25.71%;多次给予低剂量、中剂量和高剂量海参低聚肽和大豆糖肽混合物,分别显著延长小鼠常压密闭缺氧存活时间20.12%、26.11%和31.51%;单次给予高剂量海参低聚肽和大豆糖肽显著延长小鼠常压密闭缺氧存活时间16.66%和21.03%。与空白对照组比较,缺氧小鼠血液中的HGB显著升高;模型组,阳性药物组,低、中、高海参低聚肽和低、中、高大豆糖肽组小鼠血液中的RBC和HGB均显著升高;与缺氧模型组比较,多次给予低、中、高海参低聚肽和低、中、高大豆糖肽及低、中、高混合物组小鼠脑组织内LD、MDA含量和LDH活性显著降低,SOD活性明显升高。结论海参低聚肽、大豆糖肽及其两者混合物均能显著提高小鼠缺氧的耐受性。 展开更多
关键词 海参 低聚肽 大豆糖肽 抗缺氧
下载PDF
Separation of growth-stimulating peptides for Bifidobacterium from soybean conglycinin 被引量:8
2
作者 Wei-Yong Zuo Wei-Hua Chen Si-Xiang Zou 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第37期5801-5806,共6页
AIM: To isolate and identify the soybean conglycinin peptides that selectively stimulates the growth of bifidobacteria in vitro, and to investigate the effect of soybean conglycinin peptides on intestinal ecosystem i... AIM: To isolate and identify the soybean conglycinin peptides that selectively stimulates the growth of bifidobacteria in vitro, and to investigate the effect of soybean conglycinin peptides on intestinal ecosystem in vivo. METHODS: Soybean conglycinin was purified from soybean seeds by gel filtration (Sepharose-CL-6B). These proteins were submitted to hydrolysis by pepsin. Several growth-stimulating peptides for bifidobacteria were isolated chromatographically from pepsin hydrolysis of soybean conglycinin and identified by means of matrixassisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS). Parallel to in vitro study, in vivo experiments with soybean conglycinin peptides were performed in mice. Ninety male KM mice were randomly assigned into five groups of 16 mice each, and each group was administered for 21d intragastrically with physiological saline (control), conglycinin, pepsin-treated conglycinin (PTC), the most active fraction which isolated from pepsin-treated conglycinin (P2-PTC) and HCl-full hydrolysis of conglycinin (HCl-FHC), respectively. Intestinal microflora were evaluated by standard microbiologic methods and biochemical assays of cecal content samples after treatment. RESULTS: The results showed that the peptides which were isolated from soybean conglycinin could stimulate the growth of bifidobacteria in vitro, and the molecular mass of purified peptides with MALDI-TOF-MS ranged from 693.32 to 1829.55. Compared with control group, in vivo experiments showed that P2-PTC group decreased cecal pH (7.08±0.08 vs7.21±0.09, P〈0.05) and enterococcicounts (5.38±0.26 log10CFU/g vs 5.78±0.19 log10CFU/g, P〈0.05), significantly increased sIgA level (172.08±35.40 ng/g vs 118.27±33.93 ng/g, P〈0.01) and β-galactosidase activity (1.28±0.23 U/g vs 1.82±0.58 U/g, P〈0.05) CONCLUSION: The results have shown that conglycinin is good source for enzyme-mediated production of peptides which stimulate the growth of bifidobacteria. These peptides are inactive within the sequence of the parent protein but can be released during enzymatic hydrolysis, and in vivo experiments demonstrate that conglycinin peptides may be beneficial for improving gastrointestinal health. 展开更多
关键词 Conglycinin pepsin peptides bifidobacteria
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部